Dutch Research Giant TNO Shifts Strategy to Bridge Healthcare Innovation Gap
The Hague, Friday, 8 May 2026.
TNO launches major strategic pivot in 2026, moving beyond laboratory research to focus on implementing existing healthcare innovations in real-world medical settings. This shift addresses a critical bottleneck where promising health technologies fail to reach patients due to implementation challenges. The organization aims to reduce pressure on the Netherlands’ strained healthcare system while maintaining affordability through practical deployment of AI diagnostics, digital biomarkers, and remote monitoring technologies already developed but underutilized in practice.
Strategic Transformation Addresses Healthcare Innovation Valley of Death
This represents a healthcare technology innovation focused on implementing medical technologies more effectively across Dutch healthcare institutions. TNO, a major Dutch applied scientific research organization, entered a new strategic period in 2026 that significantly broadens its activities toward the healthcare sector [1][2]. The organization has traditionally focused on research and technology development but now emphasizes making innovations practically applicable in real healthcare settings [1]. Van der Zwan, a TNO representative, explains the organization’s unique positioning: “Through our independence, we can build bridges well between diverse parties, to implement innovations in practice as quickly as possible. We sit between fundamental science and the business community” [1]. This strategic pivot addresses what experts call the “valley of death” in healthcare innovation - the gap between promising laboratory developments and practical clinical implementation [3].
Digital Biomarkers and AI Diagnostics Lead Implementation Focus
The implementation strategy centers on several key technology areas where TNO has developed substantial expertise. Digital biomarkers represent a primary focus, with TNO operating a Digital Biomarker Lab that collaborates with partners like Orikami to accelerate deployment of these monitoring tools [4]. The organization has developed the Remote Data Collection Platform, built on an Orikami-licensed base, for collecting data in studies using wearables, sensors, and digital questionnaires [4]. TNO is also advancing AI applications for early disease detection, improved patient care, and better health management, emphasizing safe and reliable implementation [1]. These technologies support remote care through medical wearables that function as digital biomarkers and smart sensors [1]. The AI4HEALTH project, which received tens of millions of euros in funding from organizations including the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), specifically addresses the gap between AI solution development and practical healthcare implementation as of April 30, 2026 [3].
Addressing Healthcare System Pressure Through Technology Integration
TNO’s approach specifically targets reducing pressure on the Dutch healthcare system while maintaining affordability through labor-saving and supportive technologies [1]. The organization emphasizes that technology should take over tasks from healthcare providers while keeping caregivers “in the loop” and supporting the relationship between healthcare providers and patients [1]. Van der Zwan clarifies this philosophy: “Technology can take over tasks from healthcare providers, but ultimately it’s about supporting employees. Care always remains human work, so healthcare providers must stay in the loop. This means co-creating with healthcare providers” [1]. The TNO Health & Work division focuses specifically on increasing labor productivity, sustainable employability, and preventing absenteeism in healthcare settings [1]. The organization has developed the TNO Health@Work concept to address hormone-related complaints affecting women’s productivity in healthcare [1].
Multi-Million Euro Investment Accelerates AI Healthcare Implementation
Significant financial backing supports this implementation strategy, with multiple large-scale projects receiving substantial funding in 2026. The KIC program from NWO allocated €65 million across four consortia for long-term transdisciplinary research, with industry and other organizations adding an additional €182 million [5]. The AI4HEALTH project alone represents part of this major investment, led by UMC Utrecht and involving 38 co-applicants from various Dutch universities and medical centers [5][6]. TNO participates as a key partner alongside institutions including Maastricht University, Universitair Medisch Centrum Groningen, Amsterdam UMC, Universiteit Utrecht, and Technische Universiteit Eindhoven [6]. Private sector involvement includes major healthcare technology companies such as Philips, Medtronics, Siemens Healthineers BV, and F. Hoffmann-La Roche [5][6]. TNO collaborates annually with approximately 3,000 partners on joint challenges, demonstrating the scale of its implementation network [2]. The FIRSTLINE project, funded by Health Holland, specifically involves Dutch medical technology SMEs and TNO collaborating on safe use of medical sensors and wearables at home [1].